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Genetic screens performed inworms identifiedmajor
regulators of the epidermal growth factor receptor
(EGFR) pathway, including the ubiquitin ligase Cbl/
SLI-1. Here we focus on the less-characterized Lst2
protein and confirm suppression of MAPK signals.
Unexpectedly, human Lst2, a monoubiquitinylated
phosphoprotein, does not localize to endosomes,
despite an intrinsic phosphoinositol-binding FYVE
domain. By constructing an ubiquitinylation-defec-
tive mutant and an ubiquitin fusion, we conclude that
endosomal localization of Lst2, along with an ability
to divert incoming EGFR molecules to degradation
in lysosomes, is regulated by ubiquitinylation/deubi-
quitinylationcycles.Consistentwithbifurcating roles,
Lst2 physically binds Trim3/BERP, which interacts
with Hrs and a complex that biases cargo recycling.
These results establish an ubiquitin-based endoso-
mal switchof receptor sorting, functionally equivalent
to the mechanism inactivating Hrs via monoubiquiti-
nylation.
INTRODUCTION
To ensure fidelity of signaling outcomes, activated receptor
tyrosine kinases (RTKs), such as the epidermal growth factor
receptor (EGFR), are subjected to signal desensitizing mecha-
nisms, primarily entailing accelerated endocytosis and degrada-
tion in lysosomes (Sorkin and Goh, 2008). Activated receptors
concentrate over clathrin-coated pits at the plasma membrane,
which invaginate to form coated vesicles. Vesicles then uncoat
prior to fusing with tubulo-vesicular organelles, denoted early
endosomes (EEs). Receptor cargos subsequently undergo sort-
ing, either for recycling back to the plasmamembrane or for lyso-
somal destruction at late endosomal compartments termed
multivesicular bodies (MVBs). RTKs often undergo ubiquitinyla-
tion through recruitment of Cbl family ubiquitin ligases (Levko-
witz et al., 1998; Miyake et al., 1998). Mono- and oligoubiquitins
in the context of RTKs drive progression of cargos via endo-Devesomes, toward lysosomes (Haglund et al., 2003; Huang et al.,
2006; Mosesson et al., 2003). Active sorting in endosomes is
attributed to various ubiquitin-binding domains (UBDs) carried
by multiple adaptors (Hurley et al., 2006).
Small GTPases of the Rab subfamily are also attributed pivotal
functions; enrichment of specific Rabs in different endosomal
compartments permits local activation of a particular comple-
ment of effectors, which execute requisite endocytic tasks
(Zerial and McBride, 2001). Activated Rab5, which operates at
the cell surface/EE interface, stimulates production of phospha-
tidylinositol 3-phosphate (PI3P) in EE membranes, thereby
nucleating complexes of effector proteins like EEA1, which
harbors a PI3P-binding domain called FYVE (Stenmark et al.,
1996). In addition to EEA1, 30 other proteins share the double
zinc finger FYVE motif. Notably, PI3P binding by specific FYVE
domain proteins is highly regulated both in cis and in trans. For
example, a FYVE-containing amino-terminal fragment of Hrs
failed to localize to EEs. This may be attributed to ancillary inter-
actions involving the flanking coiled-coil domain (Raiborg et al.,
2001), or dimerization of FYVE domains (Hayakawa et al.,
2004). Similarly, the FYVE domain of EEA1 may not suffice for
endosomal localization (Hayakawa et al., 2004). Instead, endo-
somal localization of EEA1 is thought to be complemented in
living cells by p38-induced phosphorylation (Mace et al., 2005).
Thus, FYVE-mediated localization of a variety of endocytic
adaptors to EEs is a multifocal regulatory node that impacts on
both endocytosis and signaling. The present study extends the
complexity to regulation by monoubiquitinylation.
Here, we describe amammalian FYVE domain protein, termed
hLst2, whose endosomal localization is regulated by monoubi-
quitinylation. Consistent with its primitive ortholog in C. elegans,
which functions as a negative regulator of the worm’s EGFR
(Yoo et al., 2004), cellular depletion of human Lst2 augments
EGF-induced signaling. Like many endosomal adaptors, hLst2
undergoes constitutive monoubiquitinylation, but despite the
intrinsic FYVE domain, it displays primarily nonendosomal local-
ization. By identifying a specific lysine acceptor, we discover
monoubiquitinylation as a means to prevent FYVE domain-
dependent association of hLst2 with PI3P-enriched endosomes.
In line with a unique ubiquitin/PI3P switch, a nonubiquitinylated
hLst2 localizes to EEs, promotes degradative sorting of acti-
vated EGFRs, and reduces signaling.lopmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inc. 687
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Lst2 and EGFR EndocytosisFigure 1. hLst2, a Conserved FYVE Domain Protein, Restrains EGF Signaling
(A) Schematic depiction of hLst2; indicated are the carboxy-terminal FYVE domain and evolutionarily conserved regions we denoted NDom and CBox.
(B) Alignment of the FYVE domains of hLst2, Smad Anchor for Receptor Activation (SARA), Hrs, and EEA1.
(C and D) Lysates were prepared from several mouse tissues ([C]: Br, brain; Li, liver; Ki, kidney; ‘‘ex’’ denotes cellular extract from HEK293T cells ectopically
expressing hLst2) or from the indicated panel of cell lines (D). Thereafter, lysates were subjected to immunoprecipitation (IP), either using normal mouse serum
(ns) or mAb125 to hLst2, as indicated. Immunoprecipitates were analyzed by immunoblotting (IB) with the indicated antibodies, including mAb84 to hLst2. An
open arrowheadmarks a protein band consistent with the calculatedMWof hLst2 (96.5 kDa). The closed arrowhead indicates amajor anti-hLst2 reactive species
with slower than expected gel mobility.
(E) HeLa cells were transfected with siRNAs targeting either hLst2 or c-Cbl, or with control oligonucleotides. Cell lysates were subjected to IB with the indicated
antibodies, either directly or following IP with an anti-Lst2 antibody.
(F) KB oral carcinoma cells transfected with siRNA duplexes, either control or hLst2-specific, were serum-starved for 12 hr and then stimulated with EGF
(100 ng/ml) at 37C for the indicated time intervals, or else left untreated. Subsequently, cell lysates were analyzed by IB with the antibodies indicated. Relative
amounts of EGFR normalized to Cbl levels, and similarly, phosphorylated Erk normalized to Erk2 levels, were quantified using ImageJ (http://rsb.info.nih.gov/ij)
and presented below the respective panels.
(G) Cells were transfected with control or hLst2-specific siRNA oligonucleotides and analyzed as in (F). Phosphorylated Erk levels relative to Erk2 (inset) were
quantified and depicted graphically (closed triangles, control siRNA-treated cells; closed squares, hLst2 siRNA-treated cells).RESULTS
hLst2, an Evolutionarily Conserved FYVE
Domain Protein
With a view to a potentially novel mechanism of EGFR restraint,
we focused on Lst2, a molecule described solely in worms as
a negative regulator of EGFR-dependent vulval morphogenesis
(Yoo et al., 2004). To identify orthologs of Lst2, the C. elegans
sequence was blasted against the NR-NCBI database. This688 Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inyielded putative sequences deriving from higher eukaryotic
species, all mapping to a single genomic locus, but no yeast
ortholog was found. The human gene (locus: 4p16) encodes
a polypeptide of 887 amino acids, which we denoted hLst2
(also termed ZFYVE28; Figure 1A). hLst2 bears an archetypal
FYVE domain, sharing several PI3P binding motifs with other
FYVE domains (Figure 1B). The majority of the hLst2 sequence,
however, does not correspond to recognized motifs. Neverthe-
less, a multiple alignment of evolutionarily distant Lst2s revealedc.
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Lst2 and EGFR Endocytosiswell-conserved regions (see Figure S1 available online),
including the amino-terminal portion (denoted ‘‘NDom’’), and
a segment upstream of the FYVE domain (denoted ‘‘CBox’’).
To study hLst2 expression and function, several monoclonal
antibodies (mAbs) to hLst2 were generated and used to probe
mouse tissues. As shown, murine Lst2 protein was highly
enriched in brain (Figure 1C, and RT-PCR data [not shown]).
For a positive control, we used a lysate of HEK293T cells trans-
fected with a Flag-hLst2 plasmid. While this presented a specific
band corresponding to the expected mass of hLst2 (96.5 kDa),
the more prominent species corresponded to an apparent MW
of 130–140 kDa (Figure 1C). Extending our analysis to a panel
of transformed human cell lines, the anomalous form of hLst2
again appeared as the major species (Figure 1D), suggesting
robust post-translational modifications.
Depletion of hLst2 in Mammalian Cells Augments
EGF Signaling
Because Lst2 negatively regulates EGFR in worms, we studied
effects of depleting hLst2 on EGFR signals. As shown, siRNA
oligonucleotides targeting hLst2 mRNA markedly, and specifi-
cally, reduced expression of hLst2 (Figure 1E). KB human
cells transfected with hLst2-specific siRNA were then assayed
for several downstream targets of EGFR. Interestingly, hLst2
depletion resulted in increased EGF signaling; specifically, we
observed consistently higher Erk phosphorylation 1 hr after
EGF stimulation. This coincided with delayed degradation of
EGFR and enhanced expression of c-Fos (Figure 1F). To corrob-
orate these data, a similar experiment was performed that
included better-resolved time intervals. As shown, cells trans-
fected with siLst2 exhibited a clear and consistent increase in
activated Erk (Figure 1G). These results indicate that hLst2 nega-
tively regulates EGF signaling to the Erk cascade, which is
consistent with the purported activity of its ortholog in worms
(Yoo et al., 2004).
Localization of hLst2 to Endosomes Is Prevented
by Intramolecular Determinants
Atypically, hLst2 ectopically expressed in HeLa cells distributed
in a nonvesicular cytoplasmic pattern (Figure 2A), distinct from
the small puncta exhibited by EEA1 (Figure 2B), a well-character-
ized resident of endosomes. As expected, an overexpressed Hrs
manifested in aberrant structures (class E phenotype), but
ectopic hLst2 did not coincide (Figure 2B). These observations
argue against an endosomal role for hLst2. Strikingly, an isolated
FYVE domain coupled to a green fluorescent protein (GFP-
hLst2FYVE) exhibited clear punctate distribution, which could be
dissipated upon inhibition of PI3P production with wortmannin
(Figure 2C), and significantly overlapped with EEA1 (Figure 2D).
Hence, the FYVE domain in hLst2 bears autonomous avidity for
putative PI3P-containing membranes. Assuming that the FYVE
domain of hLst2 might be hindered by in cis interactions with
the highly conserved NDom or CBox regions (Figure 2E), we
prepared a series of deletion mutants, individually lacking one
of the three conserved regions. Remarkably, removal of either
theNDomor theCBox redistributed hLst2 topunctate structures,
while the FYVE domain deletion showed no detectable change
(Figure 2F). Further, GFP-Rab5, which serves as a marker for
early endosomes, exhibited considerable overlap with either ofDevthe twomutants (Figure 2G, anddata not shown). Taken together,
these results suggest that FYVE-dependent docking of hLst2 at
PI3P-containing membranes may be hampered by mechanisms
involving either NDom or CBox (see a summary of the results in
Figure 2G).
hLst2 Is a Phosphoprotein and Undergoes CBox-
Dependent Monoubiquitinylation at a Conserved Lysine
Acceptor
To address post-translational modifications, ectopic hLst2 was
isolated, and tryptic peptideswere subjected to LC-MS/MSanal-
ysis. Positive identifications included a subset of peptides
derived from ubiquitin (data not shown). Further, after factoring
in supplementary masses correlating with ubiquitinylation and
phosphorylation, our analysis revealed the presence in hLst2 of
a single lysine residue modified by ubiquitin (K87; Figure 3A), as
well as at least two phospho-acceptor sites (S586 and T870).
Immunoblotting analyses corroborated these results: incubation
of hLst2 with a broad reactivity phosphatase resulted in
increased gel mobility (Figure 3B), and anti-ubiquitin antibodies
detected constitutive ubiquitinylation, which was enhanced
upon transfection of ectopic ubiquitin (Figure 3C). Based on the
similar electrophoreticmobility of the endogenous hLst2 (Figures
1C and 1D), we assume that rich post-translational modification
is an attribute of this protein. Focusing on lysine-87, we noted
that this residue is one of three conserved lysines within the
NDom. Indeed, mutation of lysine-87 abolished ubiquitinylation
of hLst2 concomitant with a reduction in apparent molecular
weight, while the other candidates showed no effect (Figure 3D).
These results suggest modification of hLst2 by a single ubiquitin
moiety, rather than polyubiquitin chains. Examining this further,
a ubiquitin construct lacking major lysine residues that partici-
pate in chain elongation (denoted Ub4KR) was employed. As
depicted, this mutant recapitulated the wild-type pattern in the
context of hLst2, against a background of diminished polyubiqui-
tinylation (Figure 3E). In addition, using an inhibitor of the 26Spro-
teasome (MG132), we detected no effect on hLst2 levels, in line
withmonoubiquitin serving a nonproteolytic role. Together, these
observations strongly support predominant monoubiquitinyla-
tion of hLst2.
As a basic feature of hLst2 protein, we focused on the
sequence determinants of monoubiquitinylation. Interestingly,
as well as deletion of the NDom (which harbors the acceptor
lysine), the hLst2 mutant lacking the CBox was also unable to
undergo ubiquitinylation, while the FYVE domain appeared
dispensable (Figure 3F). These results indicate that the CBox
is critically involved in mediating hLst2 ubiquitinylation and,
conversely, that a capacity to dock at PI3P-containing mem-
branes is probably not required. It was also notable that all tested
versions of hLst2 maintained a sizable mobility shift that could
not be accounted for by ubiquitinylation and phosphorylation
combined. Hence, a mutant lacking the relatively unconserved
central portion of hLst2 (DM) and the complementary region in
isolation (MDom) was examined. As shown, whereas MDom
retained relatively slow gel mobility, DM appeared consistent
with its molecular weight (50 kDa; Figure 3G). Employing
mass spectrometry, however, we were unable to detect any
further post-translational modification of p130-p140 (data not
shown). In addition, the discrepancy between p130-p140 andelopmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inc. 689
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Lst2 and EGFR EndocytosisFigure 2. Endosomal Localization of hLst2 Is Prevented in cis by Either of the NDom or CBox Regions
(A) HeLa cells transiently expressing HA-tagged hLst2 were fixed, permeabilized, and incubated with an anti-HA antibody. Subsequently, cells were incubated
with a Cy3-labeled secondary antibody and examined by fluorescence microscopy. Shown is a confocal image of a representative cell. Scale bar, 10 mm.
(B) HeLa cells expressing HA-hLst2, either alone or together with Flag-Hrs, were processed for fluorescencemicroscopy using an anti-HA antibody, and either an
anti-EEA1 or an anti-Flag antibody. Appropriate secondary antibodies were used for detection. Merged images indicating the distributions of EEA1 or Hrs (green)
and hLst2 (red) are shown.
(C) HeLa cells transfected with the FYVE domain of hLst2 (aa 761–887) fused to GFP (GFP-hLst2FYVE) were treated with wortmannin (100 nM) for 30 min or left
untreated. Thereafter, cells were fixed and analyzed directly by fluorescence microscopy.
(D) HeLa cells expressing GFP-hLst2FYVE were fixed, permeabilized, and incubated with an anti-EEA1 antibody, followed by a Cy3-conjugated secondary anti-
body. Confocal images showing the relative distributions of hLst2FYVE (green) and EEA1 (red) are presented.
(E) Alignment of the CBox derived from putative metazoan orthologs of hLst2 (Gg, G. gallus; Hs, H. sapiens; Ce, C. elegans; Xl, X. laevis; Dm, D. melanogaster).
(F) HeLa cells transfected with vectors encoding Flag-hLst2 or various deletion mutants thereof, as indicated, were analyzed as in (A).
(G) HeLa cells coexpressing Flag-hLst2DCBox together with GFP-tagged Rab5 were analyzed as in (D). A scheme of the described deletion mutants of hLst2,
individually lacking the NDom, CBox, or FYVE domain (DNDom, DCBox, or DFYVE, respectively), along with a summary of their endosomal status, is shown.p97 remains unknown; the latter reacted with all antibodies to
hLst2 (data not shown), underwent ubiquitinylation (Figure 3F),
and co-overexpressed with the longer form upon transfection.
Notably, however, our results identify hLst2 as a robust target
for phosphorylation and CBox-mediated monoubiquitinylation.
Monoubiquitinylation of hLst2 Regulates Its Endosomal
Localization
Because our results correlated endosomal localization of Lst2
with a lack of ubiquitinylation, we tested whether the largely non-
ubiquitinylated mutant (hLst2K87R) coincides with endosomes.690 Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier InAddressing this, we employed live-cell confocal microscopy to
follow HeLa cells stably expressing GFP-tagged hLst2. Remark-
ably, GFP-hLst2K87R protein was indeed found to concentrate in
clear puncta; GFP-hLst2WT, in contrast, displayed a dynamic,
mainly reticular-like distribution (Figure 4A; Movies S1 and S2).
Further, overexpression of hLst2K87R manifested aberrantly
enlarged endosomes, while a FYVE-disabling cysteine mutation
(hLst2K87R/C823A) abolished vesicular localization (Figure S2A),
congruent with ubiquitinylation-mediated redistribution. On the
other hand, the dynamic reticular pattern of hLst2WT was associ-
ated with microtubules, and it underwent redistribution uponc.
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Lst2 and EGFR Endocytosistreatment with a microtubule-severing agent, nocodazole
(Figure S4 and Movies S3 and S4). To verify targeting of
hLst2K87R to PI3P-enriched endosomes, we compared its distri-
bution with that of two FYVE-containing endosomal proteins,
EEA1 and Hrs. As shown, the results confirmed considerable
colocalization of hLst2K87R with both proteins (Figure 4B). More-
over, employing various fluorescently-tagged Rab GTPases,
we found that hLst2K87R exhibited significant overlap with
three of the tested Rabs (5, 4, and 7) but was segregated from
Rab11-containing structures (Figure S2B), in line with enrich-
ment of PI3P in early and sorting endosomes (Vicinanza et al.,
2008).
To directly test whethermonoubiquitinylation prevents binding
of the FYVE domain to PI3P-enrichedmembranes, we incubated
hLst2 proteins with immobilized phosphoinositides. Specifically,
hLst2WT or hLst2K87R was fused to aHis6-Flag tag and expressed
inHEK293Tcells. Nickel-purified proteins, alongwith the isolated
FYVE domain and a disabled point mutant thereof (FYVEC823A),
Figure 3. hLst2 Undergoes Constitutive Phosphorylation and CBox-Dependent Monoubiquitinylation
(A) Flag-hLst2 immunoprecipitates isolated from transfected HEK293T cells were gel-resolved and stained, and the major specific band (apparent molecular
weight p130–140) was excised and then analyzed by mass spectrometry. Results identifying a single ubiquitinylation site and two phosphorylation sites in
hLst2 are depicted in the table.
(B) Lysates of HEK293T cells expressing Flag-hLst2 were subjected to IP using an anti-Flag antibody. Immunoprecipitates were treated with calf intestinal phos-
phatase (CIP) or left untreated, as indicated, before immunoblotting (IB).
(C) Lysates of HEK293T cells expressing Flag-hLst2 and HA-ubiquitin (HA-Ub) were subjected to IP and IB with the indicated antibodies, including an antibody to
ubiquitin.
(D) Lysates of HeLa cells expressing HA-Ub together withwild-type Flag-hLst2WT or the indicated lysine-to-arginine point mutants thereof (Lst2K87R, hLst2K187R or
hLst2K266R) were analyzed as in (C).
(E) HeLa cells transiently transfected with an expression vector for Flag-hLst2, together with plasmids encoding either Myc-ubiquitin (Myc-UbWT) or a multiple
lysine mutant thereof (K11/29/48/63R; denoted Myc-Ub4KR), were treated with MG132 (12.5 mM) for 4 hr at 37C or else left untreated, as indicated. Thereafter,
cell lysates were analyzed as indicated. Note that the slightly lower ubiquitinylation of hLst2 in the presence of Ub4KR was not reproducible.
(F) HEK293T cells expressing HA-ubiquitin (HA-Ub) together with Flag-hLst2; either wild-type (WT) or the deletion mutants indicated were lysed and analyzed
as in (D).
(G) Top: scheme showing the central portion of hLst2 in isolation (hLst2MDom) and a complementary deletion mutant lacking this region (hLst2-DM). Bottom:
HEK293T cells transiently expressing Flag-hLst2 (WT), or the indicated deletion mutants thereof, were lysed and analyzed using an anti-Flag antibody. Black
and open arrowheads are as described in Figure 1C; an asterisk and a pair of asterisks, respectively, indicate the observed and predicted gel mobility of
hLst2MDom.Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inc. 691
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Lst2 and EGFR EndocytosisFigure 4. Monoubiquitinylation of hLst2
Disables FYVE Domain-Dependent Target-
ing to Sorting Endosomes
(A) Confocal sections of live HeLa cells stably ex-
pressing GFP-tagged hLst2WT or hLst2K87R, along
withmagnification of the squaredareaof eachpanel
(inset). Note that hLst2WT exhibits largely reticular
patterns, andpossibly some small vesicles (arrows),
but themutant is largely vesicular. Scale bar, 10 mm.
(B) HeLa cells ectopically expressing GFP-
hLst2K87R, either alone (upper row), or together
with HA-tagged Hrs (lower row) were fixed, per-
meabilized, and incubated either with an anti-
EEA1 antibody (upper row) or an anti-HA antibody
(lower row), followed by an appropriate Cy3-
labeled secondary antibody. Shown are confocal
images of representative cells; a magnification of
the indicated area within the merge pane is also
depicted (inset). Scale bar, 10 mm.
(C) HEK293T cells were transfected with vectors
encoding His6-Flag-tagged hLst2, either wild-
type (WT), the lysine point mutant (K87R), the iso-
lated FYVE domain (hLst2FYVE), or a disabled point
mutant thereof (FYVEC823A). Cell lysateswere incu-
bated with a nickel resin, and immobilized proteins
were subsequently eluted in 250 mM imidazole.
Equivalent amounts of the indicated hLst2 proteins
were then incubated with PI3P-agarose beads,
beforewashing andanalysisbygel electrophoresis
and IBwith ananti-Flag antibody.Openand closed
arrowheads are as in Figure 1C.
(D) The indicated hLst2 proteins were isolated as in
(C) and incubated with nitrocellulose membranes,
which were prebound to the indicated panel of
phospholipids (see rectangle). Thereafter, mem-
branes were probed with an anti-Flag antibody.
Abbreviations: LPC, lysophosphocholine; LPA,
lysophosphatidic acid; PI, phosphoinositol; PI(3)P,
phosphoinositol 3-phosphate; PI(4)P, phosphoino-
sitol 4-phosphate; PI(5)P, phosphoinositol 5-phos-
phate; S1P, sphingosine 1-phosphate; PI(3,4)P2,
phosphoinositol (3,4)-bisphosphate; PI(3,5)P2,
phosphoinositol (3,5)-bisphosphate; PI(4,5)P2,
phosphoinositol (4,5)-bisphosphate; PI(3,4,5)P2,
phosphoinositol (3,4,5)-trisphosphate; PA, phos-
phatidic acid.
(E) HeLa cells were transiently transfected with constructs encoding a Flag-tagged ubiquitinylation-defective point mutant of hLst2 (Flag-hLst2K87R), a chimera
comprised of hLst2K87R fused at the amino terminus to an ubiquitin moiety (Flag-UbWT::hLst2K87R), or a derivative chimera that includes an isoleucine-44 muta-
tion within the ubiquitin moiety (Flag-UbI44A::hLst2K87R). Thereafter, cells were fixed, permeabilized, and incubated with an anti-Flag antibody, followed by an
appropriated Cy3-labeled secondary antibody. Confocal images of representative cells are shown; a magnification the boxed area is also depicted (inset). Scale
bar, 10 mm.were incubated with PI3P-conjugated beads prior to immuno-
blotting. As expected, the isolated FYVE domain remained
bound to the PI3P resin, while the mutant did not (Figure 4C).
Furthermore, whereas hLst2WT exhibited onlyminimal interaction
with PI3P, hLst2K87R displayed enhancedbinding (Figure 4C). It is
notable that this assay reflected preferential binding of the p97
variant to PI3P. In line with specificity, an overlay assay
comparing various lipids corroborated the results and confirmed
FYVE’s specificity to PI3P (Figure 4D). To independently test
ubiquitinylation-dependent sequestration of hLst2 away from
PI3P-containing endosomes, an in-frame fusion of ubiquitin
with hLst2K87R was generated (UbWT::hLst2K87R); in parallel, we
tested a similar construct incorporating a mutation within the692 Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inubiquitin moiety (isoleucine-44-to-alanine) at a locus commonly
accessed by UBDs (UbI44A::hLst2K87R; depicted in Figure S3A).
Expression of the chimeric proteinswas confirmed inmammalian
cells (Figure S3B), and their localization analyzed by immunoflu-
orescence microscopy. As shown, the UbWT::hLst2K87R fusion
assumed a diffuse pattern, in contrast to the punctate appear-
ance of both hLst2K87R and the UbI44A::hLst2K87R chimera
(Figure 4E). Predictably, the latter chimera significantly coincided
with a coexpressed Hrs, but UbWT::hLst2K87R did not (Figure
S3C). Overall, these results ascribe to ubiquitin an in cis
inhibitory effect on hLst2 binding to PI3P, probably by recruiting
a ubiquitin-binding protein(s) to the isoleucine-44-centered
hydrophobic patch.c.
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Lst2 and EGFR EndocytosisFigure 5. Endosomal hLst2 Accelerates Ligand-Induced EGF Receptor Degradation
(A) Confocal sections were obtained 30min after adding Alexa-fluor555-conjugated EGF (0.5 mg/ml) to HeLa cells expressingGFP-hLst2, eitherWT or K87R. Note
the limited colocalization of hLst2WT and EGF (arrowheads in insets), as opposed to the extensive colocalization of hLst2K87R with EGF. Scale bar, 10 mm.
(B and C) HeLa cells stably expressing a siRNA expression construct targeting EGFR (HeLa-sEGFR) were transiently transfected with plasmids encoding siRNA-
refractory EGFR, GFP, and as indicated, Flag-hLst2, either wild-type (WT) or the ubiquitinylation-defectivemutant (K87R). Thirty-six hours post-transfection, cells
were serum-starved for 12 hr and stimulated with either EGF (10 ng/ml [B]) or TGF-alpha (20 ng/ml [C]) at 37C for the indicated time periods. Thereafter, cell
lysates were subjected to analysis with the indicated antibodies. Relative amounts of EGFR normalized to GFP levels are presented below the upper panel; quan-
tification of bands was performed using ImageJ.
(D) HeLa cells were cotransfected with plasmids encoding a SRE-luciferase reporter, GFP, and the indicated forms of hLst2. Following serum starvation, cells
were treated with EGF (black columns) for 8 hr or else left untreated (white columns). Thereafter, cells were lysed, and the luminescence signal measured. Results
were normalized to the GFP signal and are presented as mean values (and SD [bars]).
(E) HeLa cells expressing HA-tagged hLst2 were serum-starved for 12 hr before treatment with EGF (100 ng/ml) at 37C for the indicated time periods. Thereafter,
cells were lysed and analyzed by IB using an anti-HA antibody.
(F) Cells transiently expressing either wild-type HA-hLst2 (upper panel) or the Flag-tagged central portion of hLst2 (Flag-MDom; lower panels) were serum-
starved for 12 hr. Thereafter, cells were pretreated with a MEK inhibitor (UO126; 5 mM) or with wortmannin (100 nM) for 30 min at 37C or else left untreated,
as indicated, before stimulation with EGF (20 ng/ml) for the indicated time intervals and analysis with the indicated antibodies.Nonubiquitinylated hLst2 Colocalizes with EGFR
in Endosomes and Promotes Receptor Degradation
Conceivably, Lst2 negatively regulates EGFR signaling, both in
worms (Yoo et al., 2004) and in mammalian cells (Figures 1F
and 1G), by directly impinging on EGFR trafficking. To address
this, internalization of fluorescently labeled EGF in HeLa cells
stably expressing hLst2WT or hLst2K87R was followed by live-
cell confocal microscopy (Movies S5 and S6). As shown, theDevenonubiquitinylated mutant extensively colocalized with endocy-
tosed EGF 30 min after EGF addition; however, hLst2WT dis-
played only limited overlap (Figure 5A). Further, by transient
transfection of hLst2, we noted that in cells overexpressing
hLst2K87R, a fraction of EGFRs redistributed to large vesicles
containing the mutant, in the absence of ligand, while no such
basal effect was observed for hLst2WT (Figure S5). Of note, after
adding EGF the receptors almost exclusively colocalized withlopmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inc. 693
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Lst2 and EGFR EndocytosishLst2K87R, but stimulation with EGF exerted no detectable redis-
tribution of either ectopic form of hLst2. Receptor redistribution
by endosome-anchored hLst2 may reflect an ability to promote
EGFR degradation or inhibit recycling. To examine these
options, we made use of an engineered HeLa cell line in which
endogenous receptor levels had been silenced by stable expres-
sion of an EGFR-specific siRNA (Zwang and Yarden, 2006). By
transient transfection of hLst2 and siRNA-refractory EGFR, this
setup allowed effective monitoring of coexpressing cell popula-
tions. As shown, receptor degradation became apparent after
half an hour of treatment with EGF (Figure 5B). Upon inclusion
of hLst2, however, ligand-induced receptor degradation could
be observed already after 10 min, and the nonubiquitinylated
mutant manifested an even more pronounced destabilizing
effect. These results suggest that increased hLst2 levels
promote ligand-dependent EGFR degradation and, moreover,
that the endosomal K87R mutant is more active in this capacity.
In view of these results, we considered the possibility that
nonubiquitylated hLst2 is involved in sorting decisions, namely,
whether to recycle or degrade EGFRs. To address this, we
employed an alternative ligand for EGFR (TGFa), which is known
to favor receptor recycling (Ebner and Derynck, 1991). Indeed,
even after prolonged treatment with TGFa (up to 4 hr), we
observed limited EGFR degradation, but in the presence of
nonubiquitinylated hLst2, ligand induction resulted in a marked
receptor destabilization (Figure 5C). To further test whether the
enhanced rate of receptor degradation translates into a reduced
signaling outcome, we utilized a luciferase reporter gene fused to
the serum response element (SRE), a transcriptional target of
EGFR-activated Erk. Consistent with effects observed on EGFR
degradation, expression of hLst2K87R reduced induction of the
reporter protein, while a nonubiquitinylated mutant with a dis-
abled FYVE domain (K87R/C823A) restored similar levels of
SRE activity (Figure 5D). In sum, these results support a role for
endosomal hLst2 in promotingEGFRdownregulation in amanner
dependent on its FYVE domain and state of ubiquitinylation.
Given a negative role in EGF signaling, and the critical func-
tions played by EGFR in cancer (Citri and Yarden, 2006), the
status of hLst2 in human tumorswas of interest. For this purpose,
a large cohort (272 cases) of invasive human breast carcinomas
was employed, and sections were probed with a mAb to hLst2.
Our initial analyses revealed expression of hLst2 protein in
a subset of Luminal A type tumors (Table S1). hLst2-positive
tumors were relatively differentiated and displayed limited
metastasis to adjacent lymph nodes, in line with putative tumor
suppression activity andour signaling data. Possible implications
of low incidence of hLst2 expression in other types of cancerswill
entail further analyses.
EGF Induces Phosphorylation of hLst2
Tyrosine phosphorylation and ubiquitinylation of the Eps15
endocytic effector are regulated in an inducible manner by
EGF. We detected no EGF-induced ubiquitinylation of hLst2
(data not shown). On the other hand, the analyses described
below indicate that hLst2 is similarly phosphorylated, albeit on
serine/threonine residues. As shown, EGF treatment caused
a subtle but reproducible upshift of hLst2 (Figure 5E), which is
not due to tyrosine phosphorylation (data not shown). It is notable
that the upshift of Lst2 was minor and was not apparent in all our694 Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevierexperiments. Nevertheless, using deletionmutantswe enhanced
the inducible modification and mapped it to the central MDom
domain (Figure 5F). Further, pharmacological inhibitors indicated
that the ligand-stimulated effect is prevented by pretreatment
with a MEK inhibitor (UO126), but not with a PI3K inhibitor (wort-
mannin; Figure 5F). Hence, in addition to constitutive phosphor-
ylation, hLst2 is subjected to MEK-dependent serine/threonine
phosphorylation.
hLst2 Physically Binds Trim3, a Coordinator
of Endosomal Trafficking
To shed light onmechanistic aspects of hLst2, we aimed at iden-
tifying interacting proteins. As bait, we expressed in bacteria the
NDom of hLst2 flanked by a GST moiety and a His6 tag (denoted
GNH). Nickel-immobilized GNH was mixed with a lysate of
mouse brain, and associated proteins were eluted and then
reimmobilized on glutathione-conjugated beads. Samples were
subsequently washed in increasing salt concentrations, resolved
by electrophoresis, and visualizedwith a protein stain (Figure 6A).
Of the three specific bands we analyzed by LC-MS/MS, only the
85 kDa band yielded readable tryptic peptides, which identified
the protein as the RBCC domain protein, Trim3 (also known
as BERP or RNF22). RBCC embodies an ordered union of a
RING domain, one or two distinct zinc fingers, termed B boxes,
a coiled-coil region, and a divergent carboxyl terminus (Borden,
1998). In Trim3, additional domains complement the RBCC
(Figure 6B), including a filamin repeat, which forms rod-like
structures in several actin crosslinking proteins, and a series of
NHL repeats, resembling WD repeats in adopting a b-propeller
configuration. The proposed association between Trim3 and
hLst2 was confirmed in HEK293T cells (Figure 6C), but EGF
exerted no effect on these physical interactions (Figure 6D).
Notably, hLst2 coincides almost entirely with more peripherally
located Trim3-containing structures (Figure 6E). Hence, hLst2
apparently encounters a subpopulation of Trim3 molecules
in peripheral cytoplasmic regions. The function of Trim3 is
unknown, but interactions with two actin-associated proteins,
myosin V and a-actinin-4, have been reported (El-Husseini
et al., 2000; El-Husseini and Vincent, 1999), as well as an involve-
ment in a vesicular recycling complex termed CART (Yan et al.,
2005). As we discuss below, these features provide clues into
mechanisms underlying the ability of hLst2 to regulate vesicular
trafficking, as well as signaling by tyrosine kinases like EGFR,
both in worms and in mammals.
DISCUSSION
Internalization of cell-surface receptors, such as RTKs, remodels
and restricts their signaling capacity; yet mechanisms that
govern endocytosis are incompletely understood. In this study,
we report a unique mode of regulation, in which removal of
monoubiquitin from hLst2 activates its cargo sorting activity
and negates growth factor signaling (Figure 7), consistent with
the function of the invertebrate Lst2 uncovered through genetic
analyses (Yoo et al., 2004).
A Ubiquitinylation-Dependent Switch for PI3P Binding
Proteins that bear FYVE domains are most often targeted to
PI3P-enriched membranes, yet the steady-state distribution ofInc.
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Lst2 and EGFR EndocytosisFigure 6. Identification of Trim3 as an Inter-
acting Partner of hLst2
(A) Bacterially produced GNH (comprising the
NDom of hLst2 flanked by an amino-terminal
GST moiety and a carboxy-terminal His6 tag)
was purified on nickel-agarose beads (50 mg
protein) and incubated without or with lysate
prepared from mouse brain (30 mg protein).
Immobilized proteins were then eluted in 250 mM
imidazole and rebound to GSH-agarose beads.
For a parallel external control, we used GST alone
coupled to GSH-agarose (50 mg protein). After
extensive washes, samples were subjected to
gel electrophoresis and staining with Gel Code.
Specific bands were dispatched for mass spec-
trometry analysis. A representative stained gel is
shown. An arrow indicates the major band corre-
sponding to GNH. Asterisks mark bands specific
to the GNH sample exposed to brain lysate.
(B) Scheme depicting the domain structure of
Trim3.
(C) HEK293T cell monolayers were transfected
with plasmids encoding Flag-Trim3 and HA-hLst2,
as indicated. Forty-eight hours post-transfection,
cell lysates were subjected to IP with an anti-Flag
antibody, and IB with the indicated antibodies.
(D) HeLa cells transiently expressing HA-hLst2
and Flag-Trim3, as indicated, were serum-starved
for 12 hr and then treated with EGF (20 ng/ml at
37C) for the indicated time periods, or else left
untreated. Thereafter, cells were lysed and
analyzed with the indicated antibodies.
(E) HeLa cells coexpressing Flag-Trim3 and
HA-hLst2 were fixed, permeabilized, and incu-
bated with mouse anti-Flag and rat anti-HA
antibodies. For detection, appropriate Cy2- and
Cy3-conjugated secondary antibodies were used.
Shown are confocal images taken from the central
plane of the cell. Scale bar, 10 mm.hLst2 did not coincide with patterns exhibited by other family
members (Figure 2B). FYVE domains are, nevertheless, not
homogeneous, and sequence deviation around consensus resi-
dues may impinge on qualities of binding (Kutateladze, 2006).
Mutational analysis of the specific ubiquitin acceptor site in
hLst2 subsequently resolved this discrepancy: hLst2 monoubi-
quitinylation inhibits its PI3P binding capability (Figure 4). Our
in vitro experiments excluded the possibility that hLst2 harbors
an intrinsic ubiquitin-binding function (data not shown), which
would explain intramolecular steric hindrance of the FYVE
domain. Still, several other scenarios may explain impairment
of FYVE domain activity. First, constitutive phosphorylation of
hLst2may be involved; curiously, one of the target acceptor sites
we identified by mass spectrometry (threonine-870) resides
within the FYVE domain (Figure 3A), and phosphorylation of
EEA1 and Rabenosyn-5 within their FYVE domains promotes
endosome targeting (Mace et al., 2005). According to an alterna-
tive model, which is strongly supported by our ubiquitin-hLst2
fusion chimera (Figure 4E), ubiquitin may serve as a docking
site for an UBD-containing protein, which could hamper theDeveFYVE domain. The putative UBD proteins involved in sequestra-
tion of hLst2 may play pivotal roles in receptor sorting for degra-
dation, but their identity remains unknown.
hLst2 Regulation by E3 Ligases and Deubiquitinylating
Enzymes
The described monoubiquitin switch anticipates the existence of
an E3 ligase and deubiquitinylating enzyme pairing that acts
upon hLst2. Regarding their relative contribution, constitutive
ubiquitinylation indicates that hLst2 is robustly coupled to its
cognate ligase. To pursue possible E3 ligases, we employed
an isolated CBox as bait, but were unable to identify any recog-
nized participants of the ubiquitinylation machinery (data not
shown). A growing list of ligases is associated with endocytic
processes: Cbl and Nedd4 family proteins, as well as Trim3,
however, did not influence hLst2 ubiquitinylation (data not
shown). Other feasible possibilities includemultiple ligases impli-
cated in trafficking within the Notch pathway, such asMindbomb
and Neuralised, Parkin, which targets Eps15, and Mdm2, which
ubiquitinylates b-arrestin. On the opposing side, it will be criticallopmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Inc. 695
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ligases, several DUBs have emerged as potential regulators of
endocytosis. For instance, genetic and biochemical studies
implicate the Drosophila protein ‘‘fat facets’’ and its mammalian
ortholog, FAM, as cognate DUBs for Epsin proteins (Chen et al.,
2002). AMSH and UBPY are DUBs that both converge on the
STAM adaptor protein. Interestingly, these enzymes appear to
exert opposing effects on lysosomal degradation of activated
RTKs, though their precise involvement remains unclear (Alwan
and van Leeuwen, 2007; McCullough et al., 2006).
Ubiquitinylation-Dependent Sequestration from
Endosomes: An Emerging Motif to Regulate Trafficking
and Signaling
Multiple endosomal adaptor proteins undergo ubiquitin conjuga-
tion, which is often not associated with their proteasomal degra-
dation (Mukhopadhyay and Riezman, 2007), but consequences
of adaptor ubiquitinylation remain unclear. Several reports point
to a role in regulation of subcellular localization: for instance,
monoubiquitinylation of endocytic proteins, such as Eps15 and
Sts2, may result in intramolecular interactions between self-
ubiquitin and their UBDs, which may prevent adaptor associa-
tion with other ubiquitinylated targets (Hoeller et al., 2006).
Likewise, a recent study into regulation of Rabex-5 reports that
while endosomal localization of Rabex-5 is dependent on its
Figure 7. Proposed Model for Lst2 Function in EGFR Endocytosis
The scheme depicts localization of the Lst2 protein to PI3P-enriched early
endosomes, by virtue of its FYVE domain. Lst2 undergoes monoubiquitinyla-
tion at a conserved lysine residue (lysine-87), which results in impairment of
its FYVE domain, and sequestration from endosomes (inset). Accordingly,
we envisage an ubiquitinylation/deubiquitinylation cycle that allows intermit-
tent recruitment of Lst2 to sorting endosomes during EGFR trafficking. In
comparison, the extensively characterized FYVE domain protein, Hrs, remains
membrane bound despite its ubiquitinylation by Nedd4 family E3 ubiquitin
ligases. Note that EGF-induced and MAPK-mediated serine/threonine phos-
phorylation of Lst2 contrasts with tyrosine phosphorylation of Hrs. We find
that Lst2 associates with the RBCC protein, Trim3, which in turn couples to
the CART cargo recycling complex, comprising a-actinin-4 and myosin V.696 Developmental Cell 16, 687–698, May 19, 2009 ª2009 Elsevier Iubiquitin-binding capability, the monoubiquinylated protein
appears enriched in the cytosol (Mattera and Bonifacino,
2008). Hence, aswith Lst2, ubiquitinylation-mediated sequestra-
tion of endosomal adaptors from target membranes may prove
to be a widespread regulatory mechanism. In this scenario,
an ubiquitinylation/deubiquitinylation cycle may operate in
temporal and spatial coordination with receptor trafficking,
thereby enabling timely engagement of Lst2 and other ubiqui-
tin-conjugated endocytic effector proteins, such as Hrs (see
Figure 7).
An Emergent Sorting Machinery Involving Trim3
By a yeast two-hybrid screen, the carboxy-terminal b-propeller
regionof rat Trim3was found to interactwithunconventional class
Vmyosins (El-Husseini and Vincent, 1999). Myosin V proteins are
highly processive actin-based molecular motors that function in
transport of diverse intracellular cargoes (Reck-Peterson et al.,
2000). In a further screen using the RBCC domain of Trim3, an
interaction was reported with the nonmuscle actin-bundling
protein, a-actinin-4 (El-Husseini et al., 2000). The so-called
‘‘CART’’ complex (comprising Hrs, a-actinin-4, myosin V, and
Trim3) is proposed to mediate transferrin receptor recycling,
though its disruption did not appear to affect EGFR trafficking
(Yan et al., 2005). Another study has suggested that Hrs may
actively recycle specific cargoes, such as certain GPCRs, inde-
pendently of its well-known sorting role at the MVB (Hanyaloglu
et al., 2005). Class V myosins have been widely implicated in
recycling and in transport of endosomes to the cell surface.
Hence, hLst2 may participate in a novel sorting machinery
involving Trim3, in line with the evolutionarily conserved role of
Lst2 in trafficking of RTKs. Future studies will address potential
bifurcating roles of Lst2, and associated protein complexes, in
sorting of RTKs to degradation or recycling.
EXPERIMENTAL PROCEDURES
Materials
All cell lines were from American Type Culture Collection (Manassas, VA).
Control (siGENOME Non-Targeting siRNA pool) and hLst2-specific siRNA
oligonucleotides were purchased from Dharmacon Research (Lafayette,
CO). Antibodies were from Alexis Biochemicals (San Diego, CA), Roche
Molecular Biochemicals (Mannheim, Germany; anti-HA), Covance (Princeton,
NJ; anti-ubiquitin, clone P4G7), Sigma (anti phospho-Erk and anti-Flag), and
Cell Signaling (Beverly, MA; anti-EEA1). Alexa Fluor 555-labeled EGF was
fromMolecular Probes (Eugene, OR). To generate monoclonal anti-hLst2 anti-
bodies, mice were immunized with recombinant full-length GST-hLst2. Sple-
nocytes from a selected mouse were fused with NSO myeloma cells, and
hybridomas were selected and cloned by limiting dilution. For a polyclonal
anti-hLst2 antibody, rabbits were immunized with a recombinant amino-
terminal portion (NDom) of hLst2.
Protein-Lipid Overlay and Lipid Bead-Protein Pull-Down Assays
The overlay assay was performed using purified His-Flag-tagged hLst2
proteins and nitrocellulose membranes spotted with specific lipids (Echelon
Biosciences, Salt Lake City, UT). Albumin-blocked membranes were incu-
bated overnight at 4Cwith purified hLst2 proteins (1 mg) in TBST. Membranes
were then washed and processed for detection, using an anti-Flag antibody.
For a lipid-protein pull-down assay, PI3P-agarose beads (Echelon Biosci-
ences, Salt Lake City, UT) were incubated with purified hLst2 protein (1 mg)
in binding buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 0.25% Nonidet
P-40) for 3 hr at 4C. Tightly bound proteins were eluted by boiling in gel
sample buffer.nc.
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cDNA for human hLst2 was provided by the Kazusa Human cDNA Project and
subcloned downstream of a peptide tag by PCR into the pCDNA3 vector. The
Flag-hLst2-MDom construct was produced by PCR amplification of the central
region of hLst2 (aa 288–715). GFP-hLst2WT, GFP-hLst2K87R, and GFP-Flag-
FYVE expression vectors were generated by PCR and cloning into pEGFP-C1
(Clontech,MountainView,CA).PlasmidsencodingHis-Flag-hLst2and itsderiv-
ativesweremade by subcloning into the pcDNA3HisB vector (Invitrogen,Carls-
bad, CA). Chimeric constructs encoding in-frame fusions of ubiquitin (aa 1–75;
either wild-type or an isoleucine-44-to-alanine point mutant thereof) with
hLst2K87R (denoted UbWT::hLst2K87R and UbI44A::hLst2K87R, respectively) were
generated by overlap extension PCR, using Flag-ubiquitin- and hLst2K87R-
encoding plasmids as templates. To generate the GNH construct, an oligo-
deoxynucleotide duplex coding for a hexa-histidine tag was inserted in-frame
carboxy-terminal to the GST-NDom-expressing sequence.
Cell Lines, Transfection, Lysate Preparation, and Immunoblotting
Analyses
HeLa cells were transfected using the jetPEI reagent (PolyPlus, Illkirch, France).
A derivative cell line, stably expressesing EGFR-specific siRNA, along with
immunoblotting procedures have been described (Zwang and Yarden, 2006).
Transfection of siRNAs was performed using HiPerFect reagent (QIAGEN,
Valencia, CA).
SRE Reporter Assay
Cells were transfected with vectors encoding green fluorescent protein (GFP),
various forms of hLst2, and a plasmid containing the serum response element
(SRE) fused to a luciferase reporter gene. Thereafter, cells were split into
24-well plates and serum-starved overnight, before treatment with EGF
(20 ng/ml) for 8 hr at 37C. Light intensity was measured using a luminometer
and normalized to GFP expression levels.
Immunofluorescence Microscopy
Paraformaldehyde-fixed cells were permeabilized for 10 min at 22C with
0.2% Triton X-100. For labeling, coverslips were incubated for 1 hr at room
temperature with a primary antibody, followed by an additional hour with
Cy2- or Cy3-conjugated secondary antibodies. Confocal microscopy was per-
formed using a Zeiss Axiovert 100 TV microscope (Oberkochen, Germany)
with a 633/1.4 plan-Apochromat objective. Live-cell imaging is described in
the Supplemental Experimental Procedures.
Mass Spectrometry
GelCode-stained, excised gel bands were reduced (10 mM DTT), alkylated
(10 mM iodoacetamide), and digested overnight with trypsin (Promega, Mad-
ison, WI) at a 1:100 enzyme-to-substrate ratio. The tryptic peptides were
resolved by reverse-phase chromatography using a linear gradient of 5% to
95% acetonitrile with 0.1% formic acid. Mass spectrometry was performed
by an ion-trap mass spectrometer (LCQ-DecaXP, Thermo, San Jose, CA) in
a positive ion mode. Repetitive full MS scan was used followed by collision-
induced dissociation of the three most dominant ions selected from the first
MS scan, or from a calculated mass list.
SUPPLEMENTAL DATA
The Supplemental Data include one table, five figures, six movies, and Supple-
mental Experimental Procedures and can be found with this article online at
http://www.cell.com/developmental-cell/supplemental/S1534-5807(09)00136-1/.
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